| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,249 |
33,953 |
$2.11M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
19,218 |
18,397 |
$1.73M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,097 |
37,309 |
$1.66M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
26,789 |
25,811 |
$1.32M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
12,205 |
11,981 |
$1.16M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,471 |
9,321 |
$840K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,660 |
7,534 |
$800K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
18,938 |
18,192 |
$633K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
44,994 |
21,819 |
$532K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,930 |
3,795 |
$336K |
| 87634 |
|
4,463 |
4,261 |
$296K |
| 99429 |
|
6,963 |
6,844 |
$252K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25,278 |
20,592 |
$168K |
| H0049 |
Alcohol and/or drug screening |
10,412 |
10,238 |
$105K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,630 |
4,541 |
$75K |
| 99001 |
|
10,129 |
9,936 |
$74K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,520 |
2,229 |
$71K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,431 |
5,398 |
$71K |
| 90461 |
|
8,394 |
6,994 |
$50K |
| 0071A |
|
824 |
818 |
$44K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
692 |
690 |
$41K |
| 0072A |
|
679 |
677 |
$37K |
| 99000 |
|
2,730 |
2,640 |
$32K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,149 |
1,133 |
$31K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,800 |
1,081 |
$22K |
| 0001A |
|
465 |
462 |
$21K |
| 92551 |
|
24,856 |
24,245 |
$19K |
| 0002A |
|
422 |
421 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
788 |
750 |
$11K |
| 83655 |
|
864 |
857 |
$10K |
| 0054A |
|
192 |
191 |
$10K |
| S8301 |
Infection control supplies, not otherwise specified |
501 |
473 |
$9K |
| 0073A |
|
76 |
76 |
$4K |
| 99072 |
|
5,915 |
5,532 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
381 |
352 |
$4K |
| 99381 |
|
43 |
41 |
$4K |
| 90480 |
|
129 |
126 |
$3K |
| 0124A |
|
52 |
52 |
$2K |
| 87807 |
|
195 |
195 |
$2K |
| 81002 |
|
661 |
626 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
158 |
137 |
$2K |
| 85018 |
|
1,874 |
1,841 |
$1K |
| 0081A |
|
30 |
29 |
$1K |
| 99215 |
Prolong outpt/office vis |
16 |
14 |
$1K |
| 0154A |
|
27 |
27 |
$1K |
| 90474 |
|
75 |
74 |
$907.46 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
61 |
58 |
$844.54 |
| 69209 |
|
46 |
27 |
$430.69 |
| 96380 |
|
16 |
16 |
$351.28 |
| 94760 |
|
1,213 |
1,118 |
$159.38 |
| 36415 |
Collection of venous blood by venipuncture |
454 |
446 |
$105.12 |
| 96160 |
|
12 |
12 |
$43.80 |
| 96161 |
|
86 |
65 |
$3.65 |
| 90619 |
|
758 |
753 |
$0.74 |
| 90686 |
|
13,291 |
13,110 |
$0.30 |
| 90621 |
|
475 |
474 |
$0.03 |
| 90651 |
|
1,900 |
1,885 |
$0.02 |
| 90734 |
|
875 |
873 |
$0.01 |
| 99177 |
|
25,875 |
25,500 |
$0.00 |
| 94664 |
|
1,650 |
1,595 |
$0.00 |
| 90710 |
|
839 |
835 |
$0.00 |
| 90648 |
|
2,256 |
2,218 |
$0.00 |
| 90670 |
|
2,732 |
2,720 |
$0.00 |
| 91300 |
|
1,165 |
1,065 |
$0.00 |
| 90715 |
|
515 |
512 |
$0.00 |
| 90633 |
|
1,248 |
1,235 |
$0.00 |
| 99173 |
|
166 |
165 |
$0.00 |
| 91308 |
|
99 |
90 |
$0.00 |
| 91312 |
|
52 |
52 |
$0.00 |
| 90700 |
|
124 |
124 |
$0.00 |
| 90685 |
|
13 |
13 |
$0.00 |
| 90680 |
|
1,717 |
1,675 |
$0.00 |
| 1031F |
|
26,850 |
26,332 |
$0.00 |
| 90656 |
|
1,352 |
1,349 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
21,444 |
21,305 |
$0.00 |
| 91307 |
|
1,950 |
1,824 |
$0.00 |
| 90723 |
|
698 |
681 |
$0.00 |
| 90677 |
|
1,118 |
1,046 |
$0.00 |
| 90696 |
|
158 |
158 |
$0.00 |
| 91305 |
|
365 |
361 |
$0.00 |
| 91319 |
|
26 |
26 |
$0.00 |
| 90698 |
|
82 |
80 |
$0.00 |
| 36416 |
|
12 |
12 |
$0.00 |
| 91315 |
|
27 |
27 |
$0.00 |